Insider Trades25 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 9,308 | $15.44 | $1.0B | -20.19% | +302.70% | $143.8K | +0.00% | 10b5-1 | Buy Now |
| Jun 23, 2026 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 2,900 | $13.02 | $1.0B | -20.19% | +302.70% | $37.8K | +0.00% | 10b5-1 | Buy Now |
| Jun 10, 2026 | Sell | AVTX | Christopher Ryan Sullivan | Chief Financial Officer | 138 | $13.10 | $1.0B | -20.19% | +302.70% | $1.8K | -0.34% | — | Buy Now |
| Jun 10, 2026 | Sell | AVTX | Jennifer Riley | Chief Strategy Officer | 588 | $13.10 | $1.0B | -20.19% | +302.70% | $7.7K | -1.46% | — | Buy Now |
| Jun 10, 2026 | Sell | AVTX | Paul Varki | Chief Legal Officer | 1,081 | $13.10 | $1.0B | -20.19% | +302.70% | $14.2K | -3.21% | — | Buy Now |
| Jun 10, 2026 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 1,084 | $13.10 | $1.0B | -20.19% | +302.70% | $14.2K | -2.05% | — | Buy Now |
| May 28, 2026 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 1,358 | $12.02 | $1.0B | -20.19% | +302.70% | $16.3K | +0.00% | 10b5-1 | Buy Now |
| May 15, 2026 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 6,000 | $15.71 | $1.0B | -20.19% | +302.70% | $94.2K | +0.00% | 10b5-1 | Buy Now |
| May 7, 2026 | Sell | AVTX | Christopher Ryan Sullivan | Chief Financial Officer | 37,212 | $17.00 | $1.0B | -20.19% | +302.70% | $632.6K | +0.00% | 10b5-1 | Buy Now |
| May 6, 2026 | Sell | AVTX | Christopher Ryan Sullivan | Chief Financial Officer | 94,000 | $14.11 | $1.0B | -20.19% | +302.70% | $1.3M | +0.00% | 10b5-1 | Buy Now |
| May 6, 2026 | Sell | AVTX | Paul Varki | Chief Legal Officer | 150,126 | $16.35 | $1.0B | -20.19% | +302.70% | $2.5M | +0.00% | 10b5-1 | Buy Now |
| May 5, 2026 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 216,468 | $16.00 | $1.0B | -20.19% | +302.70% | $3.5M | +0.00% | 10b5-1 | Buy Now |
| Apr 29, 2026 | Sell | AVTX | Christopher Ryan Sullivan | Chief Financial Officer | 16,915 | $13.16 | $1.0B | -20.19% | +302.70% | $222.6K | -64.52% | 10b5-1 | Buy Now |
| Apr 6, 2026 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 7,940 | $15.33 | $1.0B | -20.19% | +302.70% | $121.7K | +0.00% | 10b5-1 | Buy Now |
| Apr 1, 2026 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 1,358 | $12.02 | $1.0B | -20.19% | +302.70% | $16.3K | +0.00% | 10b5-1 | Buy Now |
| Apr 1, 2026 | Sell | AVTX | Christopher Ryan Sullivan | Chief Financial Officer | 15,959 | $16.96 | $1.0B | -20.19% | +302.70% | $270.6K | -14.44% | 10b5-1 | Buy Now |
| Mar 28, 2026 | Sell | AVTX | Christopher Ryan Sullivan | Chief Financial Officer | 8,241 | $13.89 | $1.0B | -20.19% | +302.70% | $114.5K | -12.54% | — | Buy Now |
| Mar 28, 2026 | Sell | AVTX | Garry Arthur Neil | Chief Executive Officer | 21,892 | $13.89 | $1.0B | -20.19% | +302.70% | $304.1K | -12.38% | — | Buy Now |
| Mar 16, 2026 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 50,984 | $13.86 | $1.0B | -20.19% | +302.70% | $706.5K | +0.00% | — | Buy Now |
| Dec 10, 2025 | Sell | AVTX | Christopher Ryan Sullivan | Chief Financial Officer | 155 | $4.10 | $1.0B | -20.19% | +302.70% | $635.5 | -0.89% | — | Buy Now |
| Dec 10, 2025 | Sell | AVTX | Jennifer Riley | Chief Strategy Officer | 637 | $4.10 | $1.0B | -20.19% | +302.70% | $2.6K | -19.35% | — | Buy Now |
| Dec 10, 2025 | Sell | AVTX | Mittie Doyle | Chief Medical Officer | 1,013 | $4.10 | $1.0B | -20.19% | +302.70% | $4.2K | -21.86% | — | Buy Now |
| Dec 10, 2025 | Sell | AVTX | Paul Varki | Chief Legal Officer | 1,016 | $4.10 | $1.0B | -20.19% | +302.70% | $4.2K | -21.85% | — | Buy Now |
| Mar 28, 2025 | Sell | AVTX | Christopher Ryan Sullivan | Chief Financial Officer | 7,285 | $8.46 | $1.0B | -20.19% | +302.70% | $61.6K | -10.03% | — | Buy Now |
| Mar 28, 2025 | Sell | AVTX | Garry Arthur Neil | Chief Executive Officer | 17,787 | $8.46 | $1.0B | -20.19% | +302.70% | $150.5K | -9.14% | — | Buy Now |